Skip to content

To study the Ayurvedic Rasayana effect in improvement of memory

A Clinical Study to evaluate the efficacy of Vriddha Darak Rasayana in the Enhancement of Smriti wsr to Amnestic Mild Cognitive Impairment (aMCI) - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105095
Enrollment
70
Registered
2026-03-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F04- Amnestic disorder due to known physiological condition Health Condition 2: F70- Mild intellectual disabilities

Interventions

None listed

Sponsors

Kunwar Shekhar Vijendra Ayurveda Medical College and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i Participants in this study will be community dwelling persons aged 35 to 60 years diagnosed persons with amnestic mild cognitive impairment using Petersons amnestic MCI Criteria ie 1 Memory Complaint Subjective response to standardized question 2 Norrmal general Cognitive function Mini Mental State Examination score more than 25 MoCA 18 to 25 3 Intact activities of daily living ADCS ADL MCI more than 51 4 No Dementia Clinical Dementia rating score less than 1 5 Impaired memory objective evidence for age and education Word List Delayed Recall score less than 1 SD below mean memory scale ii Consented individuals will be irrespective of sex caste religion and race with MCI able to write read and understand the hindi english language will be considered for the study

Exclusion criteria

Exclusion criteria: 1 Dementia or significant cognitive impairment that interfere with daily life 2 Subjects with Alcohol use Disorders Identification Test AUDIT score more than 3 3 Pregnant women 4 Lactating mother 5 Any Systemic disorders like kidney disorders liver disorders and cardiac disorders 6 Neurological conditions like Parkinsons disease multiple sclerosis or stroke that can affect cognition 7 Psychiatric conditions like depression Schizophrenia and anxiety 8 Participants taking medications that can affect cognitive function such as sedatives and anticholinergics 9 Subjects with uncontrolled blood pressure diabetes mellitus or hypothyroidism 10 Subjects who have received treatment with any approved or investigational health supplements for improvement of cognition and memory within the past one month preceding the screening visit 11 Subjects with abnormal laboratory tests findings such as AST and ALT greater than 3 times the upper limit of normal Hb less than or equal to 8 Platelets count less than 1 lakh 12 Subjects participating in another clinical trial within the 3 months preceding the screening 13 Subjects with a history of traumatic brain injury with loss of consciousness or convulsions 14 MMSE less than 25 15 Subjects with Manda Agni

Design outcomes

Primary

MeasureTime frame
Improvement in Smriti in aMCITimepoint: 30 days

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Viveka

KSVAMC RC Gangoh UP

shagufta.malhotra@gmail.com9988646655

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026